APIs para pesquisa e impurezas
Os Ingredientes Farmacêuticos Ativos (APIs) são as substâncias nos medicamentos responsáveis por seus efeitos terapêuticos. Nesta seção, você encontrará uma ampla variedade de APIs destinados a uso em pesquisa. Esses compostos são essenciais para o desenvolvimento, teste e validação de novas formulações farmacêuticas. Na CymitQuimica, oferecemos APIs de alta qualidade para apoiar a pesquisa em descoberta e desenvolvimento de medicamentos.
Subcategorias de "APIs para pesquisa e impurezas"
- Aminoácidos e Derivados(12.441 produtos)
- Antraquinonas e Derivados(407 produtos)
- Derivados de Benzimidazol e Imidazol(10.465 produtos)
- Derivados das Benzodiazepinas(335 produtos)
- Carboidratos e Glicoconjugados(5.388 produtos)
- Ésteres e Derivados(42.307 produtos)
- Ácidos Graxos e Derivados Lipídicos(32.488 produtos)
- Flavonoides e Polifenóis(17.101 produtos)
- Radicais Livres e Agentes Oxidantes/Redutores(214 produtos)
- Cetonas e Derivados(2.692 produtos)
- Antibióticos Naturais e Semissintéticos(6.411 produtos)
- Nitrilas e Derivados Ciano(3.070 produtos)
- Nitrosaminas e Derivados(55 produtos)
- Nucleosídeos e Nucleotídeos(3.492 produtos)
- Fosfatos e Fosfonatos Orgânicos(1.205 produtos)
- Sulfonatos e Sulfatos Orgânicos(10.452 produtos)
- Compostos Organometálicos(4.425 produtos)
- Outros(6.340 produtos)
- Peptídeos e Proteínas(3.163 produtos)
- Polímeros e Derivados(100 produtos)
- Derivados de Purinas e Pirimidinas(8.975 produtos)
- Derivados de Quinazolina e Quinolina(66.221 produtos)
- Quinonas e Derivados(24.379 produtos)
- Sais e Derivados de API(92.962 produtos)
- Esteroides e Derivados(4.987 produtos)
- Sulfonamidas e Derivados(2.607 produtos)
- Terpenoides e Derivados(3.871 produtos)
- Tiazolidinedionas e Tiopiranos(2.755 produtos)
- Compostos β-Adrenérgicos(232 produtos)
Exibir 21 mais subcategorias
Foram encontrados 66884 produtos de "APIs para pesquisa e impurezas"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
2-[[[(4-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfonyl]-1H-benzimidazole
CAS:2-[[[(4-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfonyl]-1H-benzimidazole is a protonated sulfonamide that is used as an analytical method to detect the presence of other drugs in human liver tissue. It has been shown to inhibit the activity of cytochrome P450 3A4 (CYP3A4), one of the enzymes responsible for metabolizing many drugs. Bromoenol lactone and powder diffraction spectrum are two additional analytical methods that can be used to detect 2-[([(4-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfonyl]-1H-benzimidazole.
Fórmula:C18H21N3O4SPureza:Min. 95%Cor e Forma:White/Off-White SolidPeso molecular:375.44 g/mol(1S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline
CAS:(1S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline is a drug used to treat depression. It is an antidepressant drug that inhibits the reuptake of serotonin and norepinephrine in the brain by blocking their transport into the nerve cells. The drug acts as a weak inhibitor of monoamine oxidase (MAO). It also has an effect on bladder function. This compound is synthesized from 1-phenyl-2,5-dihydrothiazole by way of a sequence of reactions that includes the formation of an amine salt via reaction with phosphorus pentoxide and chloroacetic acid followed by conversion to the chloride with thionyl chloride.Fórmula:C15H15NPureza:Min. 95%Cor e Forma:White PowderPeso molecular:209.29 g/molCefazolin impurity A
CAS:Cefazolin impurity A is a by-product in the synthesis of Cefazolin, which is a drug product. It has CAS No. 30246-33-4 and is used as an impurity standard for analytical purposes. The Impurity Standard is also known as Metabolite A. Research and Development (R&D) studies are needed to identify the appropriate analytical impurities for this API, which will be reported on Pharmacopoeia's List of Impurities for reference. The high purity and custom synthesis of this API makes it ideal for use in R&D studies, HPLC standards, or niche markets.
CAS No.: 30246-33-4
Synonyms: Metabolite A
Formula: C11H14N2O5S
Molecular weight: 289.24 g/mol
Appearance: white solid powderFórmula:C11H12N4O3S3Pureza:Min. 95%Cor e Forma:PowderPeso molecular:344.44 g/molN,N-Dimethyl-3-(4-methylbenzoyl)propionamide
CAS:N,N-Dimethyl-3-(4-methylbenzoyl)propionamide is a metabolite of the antihistamine drug diphenhydramine. It is a natural impurity and an impurity standard for this drug. N,N-Dimethyl-3-(4-methylbenzoyl)propionamide can be used in pharmacopoeia to test for purity and quality of drugs, as well as for analytical purposes. It has also been used in drug development and metabolism studies.Fórmula:C13H17NO2Pureza:Min. 95%Cor e Forma:PowderPeso molecular:219.28 g/mol2-Amino-5,6-dichloro-3(4H)-quinazolineacetic acid methyl ester monohydrobromide
CAS:2-Amino-5,6-dichloro-3(4H)-quinazolineacetic acid methyl ester monohydrobromide is a metabolite of the drug product 2-amino-5,6-dichloroquinazoline acetic acid methyl ester. It is a synthetic compound that is used as an impurity standard for pharmaceuticals and other products. This chemical can be custom synthesized to meet your needs. It has been shown to have high purity and can be used in research and development or as a pharmacopoeia reference material.Fórmula:C11H12Cl2BrN3O2Pureza:Min. 95%Cor e Forma:Off-White PowderPeso molecular:369.04 g/molLercanidipine impurity A
CAS:Lercandipine Impurity A is a metabolite of the drug lercandipine. It is synthesized in the body by oxidation at the benzylic position of the cinnamoyl moiety. This impurity may be present in lercandipine-containing drugs and products, as well as in other drugs and products containing lercandipine. Lercandipine Impurity A has been shown to inhibit the metabolism of lercandipine and may also have anti-inflammatory properties. It is used as an analytical standard for HPLC, pharmacopoeia, drug development, and metabolism studies. Lercandipine Impurity A is found in the following: -Impurities of Lercandipine -Custom synthesis -Lercandipine Drug Product -Synthetic -High purity -Pharmacopoeia -Drug development
Fórmula:C19H22N2O6Pureza:Min. 95%Cor e Forma:PowderPeso molecular:374.39 g/molTenofovir isoproxil monoester
CAS:Tenofovir isoproxil monoester is a prodrug of Tenofovir, which is an antiviral drug. Tenofovir prevents the growth of HIV by interfering with the synthesis of viral DNA. The process development stage involves converting Tenofovir to its disoproxil monoester form, which has been shown to have greater antiviral activity than Tenofovir alone. This conversion process involves condensing one molecule of fumarate with two molecules of tenofovir, forming tenofovir disoproxil fumarate (TFD). TFD can be converted back to Tenofovir using hydrolysis and hydrogenation. Impurities in TFD include isopropyl tenofovir and unidentified impurities that are not present in the parent drug, tenofovir. Tenofovir Disoproxil Fumarate was also shown to be more potent than TFD and is undergoing clinical trials forFórmula:C14H22N5O7PPureza:Min. 97 Area-%Cor e Forma:White/Off-White SolidPeso molecular:403.33 g/molPentixafor
CAS:When bound with 68Ga is used in PET/CT as a diagnostic in multiple myeloma detection
Fórmula:C60H80N14O14Pureza:Min. 95%Cor e Forma:PowderPeso molecular:1,221.4 g/molDesmethyl tacrolimus
CAS:Tacrolimus is a macrolide antibiotic that binds to the calcineurin receptor and inhibits the production of cytokines. It is used to treat certain types of autoimmunity and hyperproliferation in patients with cancer, organ transplant recipients, and those who have undergone radiation therapy. The drug is available in two forms: tacrolimus (the natural form) and desmethyl tacrolimus (a metabolite). Desmethyl tacrolimus is produced by microbial transformation, which converts the natural form into a more water-soluble derivative. This conversion can be prevented by adding additives such as proton pump inhibitors or pde5 inhibitors. Symptoms of tacrolimus include hyperglycemia, hyperlipidemia, gastrointestinal disturbances, headache, fever, skin rash, diarrhea, and anemia. Tacrolimus has been shown to inhibit the activity of fk506-binding proteins in vitro and in vivo through competitive inhibition.Fórmula:C43H67NO12Pureza:Min. 90 Area-%Cor e Forma:White PowderPeso molecular:789.99 g/molD-Asp(9)-Tirzepatide
Tirzepatide impurity.Fórmula:C225H348N48O68Cor e Forma:PowderPeso molecular:4,813.5 g/molD-Ala(24)-Semaglutide
D-Ala(24)-Semaglutide is a semaglutide impurity. The amino acid at position 24 has been replaced by the D-form of the amino acid D-alanine (D-Ala). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Fórmula:C187H291N45O59Peso molecular:4,113.64 g/molSemaglutide Impurity 54 (D-Ala 18)
D-Ala(18)-Semaglutide is a semaglutide impurity. The amino acid at position 18 has been replaced by the D-form of the amino acid D-alanine (D-Ala). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Fórmula:C187H291N45O59Peso molecular:4,113.64 g/molLinear Semaglutide
Linear semaglutide, or simply L-Sema, is the semaglutide compound without the lipid side chain modification. It is essentially a linear version of the peptide.Fórmula:C152H230N42O47Peso molecular:3,397.76 g/molD-His(1)-Semaglutide
D-His(1)-Semaglutide is a semaglutide impurity. The amino acid at position 1 has been replaced by the D-form of the amino acid D-histidine (D-His). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Fórmula:C187H291N45O59Peso molecular:4,113.64 g/molDes-Glu(3)-Semaglutide
Des-Glu(3)-semaglutide is a semaglutide-related impurity. This des-amino acid form has got the glutamic acid or glutamate (Glu) amino acid from position 3 removed from the peptide chain. Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist used for managing type 2 diabetes and obesity.Fórmula:C182H284N44O56Peso molecular:3,984.53 g/molSemaglutide Impurity 101 (D-Glu 3)
D-Glu(3)-Semaglutide is a semaglutide impurity. The amino acid at position 3 has been replaced by the D-form of the amino acid D-glutamic acid (D-Glu). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Fórmula:C187H291N45O59Peso molecular:4,113.64 g/mol
![2-[[[(4-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfonyl]-1H-benzimidazole](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FIM57866.webp&w=3840&q=75)
